Graduate Student Founder
Immigrant FounderActively Raising
Serial EntrepreneurAbout
MusiQ Bio develops a noninvasive drug delivery platform using targeted microbubbles and ultrasound to deliver therapeutics across the blood-brain barrier. Their Two-Factor Authentication mechanism combines antibody-targeting and ultrasound exposure to precisely release drugs at specific brain sites, initially focusing on gene therapy delivery for Huntington's Disease.
Traction & Metrics
Fundraising
$50K
Previous Round
Products
MsQ Targeted Microbubble Platform
Patented Two-Factor Authentication drug delivery system that uses antibody-targeted microbubbles combined with focused ultrasound to noninvasively open the blood-brain barrier and deliver gene therapies directly to specific brain regions. Achieves >20x improvement in targeting selectivity versus competing microbubbles, enabling precise delivery to deep-brain sites like the striatum for Huntington's Disease treatment without invasive surgery.
Click to read more